SINT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SINT is not a good buy right now. The tape is technically weak (bearish MACD momentum) and fundamentals show severe revenue contraction in the latest quarter, with no supportive news catalysts and no proprietary buy signals today. For an impatient investor, the setup is more consistent with avoiding/exit rather than trying to catch an oversold bounce.
Price/levels: Current price 3.20 is sitting right on S1 (3.202) with next support S2 at 3.049; overhead pivot resistance is 3.45 (then 3.699). Momentum: MACD histogram is negative (-0.0555) and expanding lower, which signals bearish momentum still strengthening. RSI: RSI(6) at ~11 is deeply oversold, which can produce short-lived bounces, but oversold alone is not a buy signal when MACD is still deteriorating. Moving averages: Converging MAs suggests a potential inflection zone, but directionality is not confirmed and momentum remains down. Pattern/near-term odds: Similar-pattern stats imply slightly negative drift (next day -0.79%, next week -0.43%, next month -2.03%), which aligns with a bearish bias.
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
Insider activity is supportive: insiders are buying, with buying amount up ~809.86% over the last month. The stock is extremely oversold (RSI ~11), which can sometimes trigger a reflex bounce if selling pressure eases. Hedge funds are currently neutral (no active negative trend flagged).
No news catalysts in the last week to reverse sentiment. Pre-market shows weakness (-4.01%), suggesting sellers remain active. Technical momentum is bearish (MACD negative and expanding). Statistical pattern outlook skews slightly negative over 1D/1W/1M. Key risk from fundamentals: latest quarter shows steep revenue decline and margin compression.
Latest quarter: 2025/Q3. Revenue fell to $208K, down -73.97% YoY (sharp contraction). Net income improved YoY (loss narrowed) to -$10.258M (+64.42% YoY improvement), but profitability remains deeply negative. EPS dropped to -3.46 (-50.29% YoY), indicating per-share performance worsened despite the net loss improvement (likely impacted by share count/other items). Gross margin declined to 44.71, down -39.35% YoY, pointing to weakening unit economics. Overall: top-line and margin trends are deteriorating, which undermines the case for an immediate buy.
No analyst rating or price target change data was provided, suggesting limited/unclear Street coverage here. Without recent upgrades/target raises, there is no visible Wall Street-driven positive catalyst. Pros typically argued for small caps would be asymmetric upside and insider confidence; cons (based on available data) are severe revenue contraction, weakening margins, and bearish technical momentum. Politician/congress activity: No recent congress trading data available.
